Author:
León‑García Montserrat,Humphries Brittany,Xie Feng,Gravholt Derek L.,Golembiewski Elizabeth,Eckman Mark H.,Bates Shannon M.,Hargraves Ian,Pelayo Irene,López Sandra Redondo,Caño Juan Antonio Millón,Alcántara Milagros A. Suito,D’Souza Rohan,Shehata Nadine,Jack Susan M.,Guyatt Gordon,Perestelo‑Perez Lilisbeth,Alonso‑Coello Pablo
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. James AH. Pregnancy-associated thrombosis. Hematology Am Soc Hematol Educ Program. 2009;2009(1):277–85.
2. Kearsley R, Stocks G. Venous thromboembolism in pregnancy-diagnosis, management, and treatment. BJA Educ. 2021;21(3):117–23.
3. Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger P. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005;3:949–54.
4. Knight M, Bunch K, Tuffnell D, Shakespeare J, Kotnis R, Kenyon S, Kurinczuk JJ (Eds.) on behalf of MBRRACE-UK. Saving Lives, Improving Mothers’ Care - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015-17. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2019.
5. Bailly J, Jacobson BF, Louw S. Safety and efficacy of adjusted-dose enoxaparin in pregnant patients with increased risk for venous thromboembolic disease. Int J Gynaecol Obstet. 2019;145(1):70–5.